conivaptan has been researched along with ranitidine in 3 studies
Studies (conivaptan) | Trials (conivaptan) | Recent Studies (post-2010) (conivaptan) | Studies (ranitidine) | Trials (ranitidine) | Recent Studies (post-2010) (ranitidine) |
---|---|---|---|---|---|
188 | 17 | 64 | 85 | 0 | 29 |
188 | 17 | 64 | 5,298 | 1,788 | 445 |
Protein | Taxonomy | conivaptan (IC50) | ranitidine (IC50) |
---|---|---|---|
Potassium-transporting ATPase alpha chain 1 | Homo sapiens (human) | 0.04 | |
Acetylcholinesterase | Homo sapiens (human) | 1.475 | |
Potassium-transporting ATPase subunit beta | Homo sapiens (human) | 0.04 | |
Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 8.3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for conivaptan and ranitidine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for conivaptan and ranitidine
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |